Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04418167
Title JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations
Recruitment Suspended
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors JS InnoPharm, LLC
Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST